volixibat development code medication development possible treatment nonalcoholic steatohepatitis nash severe form nonalcoholic fatty liver disease nafld pharmacotherapy yet exists nash interest whether volixibat prove safe effective encourage development testing us food drug administration fda issued fast track volixibat ibat inhibitor meaning blocks function ibat protein ileal bile acid transporter also called solute carrier family member asbt apical acid transporter ibat highly expressed ileum found brush border membrane enterocytes responsible initial uptake bile acids particularly conjugated bile acids intestine part enterohepatic drug article relating gastrointestinal system stub help wikipedia expanding httpsenwikipediaorgwikivolixibat